Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | -5.36% | -4.33% | +55.88% |
Apr. 23 | Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target | MT |
Mar. 21 | Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024 | CI |
Financials (USD)
Sales 2024 * | 145M | Sales 2025 * | 175M | Capitalization | 398M |
---|---|---|---|---|---|
Net income 2024 * | -32M | Net income 2025 * | -9M | EV / Sales 2024 * | 2.75 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.27 x |
P/E ratio 2024 * |
-12.4
x | P/E ratio 2025 * |
-41.8
x | Employees | 126 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.05% |
Latest transcript on Heron Therapeutics, Inc.
1 day | -5.36% | ||
1 week | -4.33% | ||
Current month | -4.33% | ||
1 month | -10.77% | ||
3 months | +1.34% | ||
6 months | +322.92% | ||
Current year | +55.88% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 23-02-20 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 23-06-15 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 18-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 23-02-20 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 21-09-19 |
Craig Johnson
BRD | Director/Board Member | 62 | 14-01-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 2.65 | -5.36% | 2,169,539 |
24-04-23 | 2.8 | +8.11% | 6,563,663 |
24-04-22 | 2.59 | -1.89% | 2,089,310 |
24-04-19 | 2.64 | -2.58% | 2,308,607 |
24-04-18 | 2.71 | -2.17% | 1,818,101 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.88% | 398M | |
+4.09% | 43.84B | |
+46.51% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- HRTX Stock